Form D Explorer

Form C-AR — 20/20 Biolabs, Inc.

0001213900-24-036995 · filed 2024-04-29

Offering

Target
—
Maximum
—
Security type
—
Price per security
—
Deadline
—
Oversubscription
—

Issuer

Name
20/20 Biolabs, Inc.
CIK
1139685
Entity
Corporation
Jurisdiction
DE
Address
15810 GAITHER ROAD, SUITE 235
GAITHERSBURG, MD 20877
Phone
—

Most recent fiscal year financials

Total assets
$6,367,828
Cash
—
Short-term debt
—
Long-term debt
$229,164
Revenues
$1,424,304
COGS
$1,315,166
Taxes paid
—
Net income
$-6,391,309

Same issuer's Form D filings

View original on SEC EDGAR.